ABETAFEN Trademark

Trademark Overview

On Thursday, July 25, 2002, a trademark application was filed for ABETAFEN with the United States Patent and Trademark Office. The USPTO has given the ABETAFEN trademark a serial number of 76434615. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, April 2, 2006. This trademark is owned by BIOENVISION INC.. The ABETAFEN trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICALS, NAMELY THERAPEUTIC DRUGS ADMINISTERED IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
abetafen

General Information

Serial Number76434615
Word MarkABETAFEN
Filing DateThursday, July 25, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, April 2, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2003

Trademark Statements

Goods and ServicesPHARMACEUTICALS, NAMELY THERAPEUTIC DRUGS ADMINISTERED IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 20, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOENVISION INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10020
Party NameBIOENVISION INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10020

Trademark Events

Event DateEvent Description
Monday, June 19, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 19, 2006ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 1, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 7, 2006PAPER RECEIVED
Thursday, September 29, 2005UNDELIVERABLE MAIL - NO ACTION TAKEN
Monday, September 19, 2005PAPER RECEIVED
Thursday, September 8, 2005EXTENSION 5 GRANTED
Thursday, September 8, 2005EXTENSION 5 FILED
Thursday, September 8, 2005TEAS EXTENSION RECEIVED
Thursday, March 31, 2005EXTENSION 4 GRANTED
Friday, March 4, 2005EXTENSION 4 FILED
Friday, March 4, 2005TEAS EXTENSION RECEIVED
Tuesday, October 5, 2004EXTENSION 3 GRANTED
Wednesday, September 22, 2004EXTENSION 3 FILED
Wednesday, September 22, 2004TEAS EXTENSION RECEIVED
Wednesday, August 11, 2004CASE FILE IN TICRS
Thursday, March 18, 2004PAPER RECEIVED
Thursday, March 11, 2004EXTENSION 2 GRANTED
Thursday, March 11, 2004EXTENSION 2 FILED
Thursday, March 11, 2004TEAS EXTENSION RECEIVED
Wednesday, July 16, 2003EXTENSION 1 GRANTED
Wednesday, July 16, 2003EXTENSION 1 FILED
Wednesday, July 16, 2003PAPER RECEIVED
Tuesday, April 1, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2003PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2002NOTICE OF PUBLICATION
Monday, October 28, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 24, 2002ASSIGNED TO EXAMINER

Related Keywords

abetafen cancer autoimmune diseases treatment administered namely therapeutic drugs pharmaceuticals